David Deetz, Ativa founder and chief executive officer, created a buzz at the Next Generation Summit in Washington D.C. On August 21, David moderated a keynote panel discussion about what makes emerging technology attractive. He explained how a new approach to diagnosing primary-care patients enables far better outcomes on August 22. His talks generated a lot of buzz and queries on Ativa’s technologies.
David has been a pioneer in the biomedical and artificial intelligence industries for more than 30 years. In that time, he has founded four companies and authored 11 U.S. patents. Learn more.